Q1 2022 Earnings Roundup: Biologics and Biosimilars Update | Goodwin

Below are some highlights from first quarter 2022 earnings reports recently released by biologics and biosimilars companies: Biogen: Last week, Biogen reported total...

Related Keywords

United States ,America ,Denny Lanfear ,Samsung Biologics ,Coherus Biosciences ,Angela Hwang ,Junshi Biosciences ,Samsung Bioepis ,Pfizer ,Innovent Biologics Suzhou Co Ltd ,Biopharmaceuticals Group ,Company Full Year ,Shanghai Junshi Biosciences Co Ltd ,Full Year ,Xbrane Biopharma ,Marketing Authorization ,Innovent Biologics ,Biologics License Application ,North America ,Group President ,